Your browser doesn't support javascript.
loading
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT.
Novak, Urban; Mooyaart, Jarl E; Daskalakis, Michael; Scheid, Christof; Gabellier, Ludovic; Yakoub-Agha, Ibrahim; Ram, Ron; Forcade, Edouard; López-Corral, Lucía; Nicholson, Emma; Galli, Eugenio; Stölzel, Friedrich; Bethge, Wolfgang; Wagner-Drouet, Eva Maria; Hoogenboom, Jorinde D; Mielke, Stephan; Arber, Caroline; Simonetta, Federico; Chabannon, Christian; Kuball, Jürgen; Ruggeri, Annalisa; Malard, Florent.
  • Novak U; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Mooyaart JE; EBMT Statistical Unit, Leiden, The Netherlands.
  • Daskalakis M; Department of Medical Oncology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
  • Scheid C; University of Cologne, Cologne, Germany.
  • Gabellier L; Hematology Department, CHU Montpellier, UMR5535, Université de Montpellier, Montpellier, France.
  • Yakoub-Agha I; CHU de Lille, Lille, France.
  • Ram R; Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
  • Forcade E; CHU Bordeaux, Hopital Haut-Leveque, Pessac, France.
  • López-Corral L; Hospital Universitario de Salamanca (Spain), IBSAL, CIBERONC. Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.
  • Nicholson E; Royal Marsden Hospital, London, UK.
  • Galli E; Universita Cattolica S. Cuore, Rome, Italy.
  • Stölzel F; University Hospital Schleswig-Holstein, Kiel, Germany.
  • Bethge W; Universitaet Tuebingen, Tuebingen, Germany.
  • Wagner-Drouet EM; University Medical Center Mainz, Mainz, Germany.
  • Hoogenboom JD; EBMT Leiden Study Unit, Leiden, The Netherlands.
  • Mielke S; Karolinska University Hospital, Stockholm, Sweden.
  • Arber C; Département d'Oncologie, Service d'Hématologie et Service d'Immuno-Oncologie, CHUV Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
  • Simonetta F; Département d'Oncologie, Service d'Hématologie, Geneva, Switzerland.
  • Chabannon C; Institut Paoli-Calmettes Comprehensive Cancer Centre and Module Biothérapies du Centre d'Investigations Cliniques de Marseille, INSERM-Aix-Marseille Université-AP-HM-IPC, CBT-1409, Marseille, France.
  • Kuball J; University Medical Center Utrecht, Utrecht, The Netherlands.
  • Ruggeri A; San Raffaele Scientific Institute, Hematology and Bone Marrow Transplantation Unit, Milan, Italy.
  • Malard F; Sorbonne Université, Centre de Recherche Saint-Antoine INSERM UMRs938, Paris, France. florent.malard@inserm.fr.
Bone Marrow Transplant ; 2024 Aug 27.
Article en En | MEDLINE | ID: mdl-39192081
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2024 Tipo del documento: Article